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INTRODUCTION
The total synthesis of natural products continues to represent an important and challenging activity that
is undertaken for a variety of reasons. Pivotal among these is the need to prove chemical structure and/or
the need to obtain sufficient quantities of material for comprehensive biological evaluation. Of course,
the structurally novel features of many natural products often provide the inspiration for the develop-
ment of new methodologies and strategies [1]. Herein, we describe some of our group’s activities in the
area that involve the application of three distinct protocols for facilitating natural products synthesis,
namely the use of gem-dihalocyclopropanes as chemical building blocks, Au(I)-catalyzed cyclization
reactions, and chemoenzymatic methodologies. These are discussed separately in the following sec-
tions.
gem-DIHALOCYCLOPROPANES AS BUILDING BLOCKS IN NATURAL PRODUCTS
SYNTHESIS
gem-Dichloro- and gem-dibromocyclopropanes (2) are readily obtained through addition of the relevant
dihalocarbene to the corresponding alkene 1 (Scheme 1). The most effective protocols for achieving
these additions involve those developed by Makosza and Brinker [2]. Specifically, a solution of the
alkene 1 in chloroform or bromoform containing a phase-transfer catalyst, often a quaternary ammo-
nium salt such as triethylbenzylammonium chloride (TEBAC), is treated with 50 % aqueous sodium
hydroxide and the resulting two-phase system is stirred vigorously (or sonicated), normally at or near
room temperature. While these conditions might appear to be especially vigorous ones, in fact the
hydroxide ion concentration in the organic phase is very low and such that the carbon–carbon double
bond of allylic acetates, for example, can be successfully cyclopropanated without any accompanying
saponification of the ester unit [3].
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An important feature of gem-dihalocyclopropanes (2) is that while they are strained organic mol-
ecules they also possess a remarkable kinetic stability. Indeed, the reactivity of these systems is ortho -
gonal to most other functional groups and such that they can be carried through multi-step reaction
sequences with impunity. Yet, at the appointed time, and by treating the gem-dihalocyclopropane with
a silver salt or (less preferably) by heating it, electrocyclic ring-opening of the three-membered ring can
be effected and thereby generating the corresponding π-allyl cation 3 [3]. The precise fate of this inter-
mediate depends upon the conditions under which it is produced. When a basic environment is involved,
then deprotonation of cation 3 occurs and 2-halo-1,3-butadienes of the general form 4 are obtained.
Alternatively, a range of nucleophiles (NuH) can be added to the reaction mixture so as to intercept
cation 3 and allylic systems such as 5 are thereby formed. When unsymmetrical cations are generated,
then mixtures of regioisomeric trapping products are often encountered in cases where external nucleo -
philes are used to intercept such species. In contrast, and as illustrated below, intramolecular nucleo -
philic trapping is normally a completely regioselective process [3].
It is noteworthy that the reaction sequence 1 → 2 → 5 results in the conversion of a mono-func-
tional starting material into a tri-functional product. As such, there is a strong “value-adding” aspect to
the sequence that is further reinforced by the capacity to engage the alkenyl halide substructure within
compound 5 in palladium-catalyzed cross-coupling reactions and thereby replacing the halogen with
carbon-based groups (of course, the same cross-coupling processes can be applied to halodiene 4).
Another interesting feature of this reaction sequence is the capacity it provides for the stereocontrolled
synthesis of tri- and tetra-substituted carbon–carbon double bonds, something that is often difficult to
achieve by more conventional means.
A subset of gem-dihalocyclopropanes of particular interest to us are those systems arising from
dihalocarbene addition to cyclopentenes. This is because these bicyclo[3.1.0]hexanes (6) lead, upon
electrocyclic ring opening, to functionalized and synthetically valuable cyclohexenes. Such processes
are facilitated by the extra strain incorporated within these ring-fused systems. Furthermore, within the
bicyclo[3.1.0]hexane framework there are four distinct positions, at C1, C2, C3, and C6, where tethered
nucleophiles can be introduced and thereby allowing for the trapping of the derived π-allyl cation in an
intramolecular fashion (Scheme 2). Thus, for example, reaction of the C1 tethered system 7 should pro-
vide a spirocyclic product of the form 8 while the analogous C2 tethered system 9 should lead to the
ring-fused system 10. In each instance, the tethered nucleophile would be expected, on kinetic grounds,
to attack the proximate rather than the remote terminus of the intermediate π-allyl cation.
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Scheme 1
The utility of the first of these processes described above has been demonstrated during the course
of our synthesis of the non-natural or (+)-enantiomeric form of the erythrina alkaloid (–)-erythramine
(11) [4].
The key substrate used in the synthesis was the gem-dichlorocyclopropane 12 (Scheme 3) which could
be prepared, as a mixture of diastereoisomers, through the addition of dichlorocarbene to the corre-
sponding alkene [4]. This alkene was itself generated through Suzuki–Miyaura cross-coupling of the
corresponding and enantiomerically pure cyclopentenyl triflate to the relevant arylboronic acid. The
pivotal spirocyclization event was carried out by first treating compound 12 with LiHMDS, to deproto-
nate at nitrogen, and then reacting the resulting conjugate base with silver tetrafluoroborate. By such
means, a chromatographically separable mixture of compound 13 (30 %) and its C5 epimer (26 %) was
obtained. The completion of the synthesis required establishment of an ethylene bridge between nitro-
gen and sp2-hydridized carbon bearing the chlorine in product 13. In our first attempts to effect this con-
version, compound 13 was treated with various alkyl lithiums in an effort to metallate the halogenated
carbon and then react this with, for example, ethylene oxide. However, despite extensive experimenta-
tion, all efforts to replace the chlorine in compound 13 with anything other than hydrogen failed.
Accordingly, the illustrated means for completing the synthesis was established. Thus, compound 13
was treated with Pd[0] and dimedone so as to remove the Alloc-protecting group at nitrogen and the
resulting 2º-amine 14 (90 %) was then treated with ethylene oxide to afford the hydroxy-amine 15
(60 %), the structure of which was confirmed by single-crystal X-ray analysis. Alcohol 15 was then
converted into the corresponding iodide 16 under standard conditions. Treatment of this iodide with
n-Bu3SnH resulted in homolysis of the C–I bond and the ensuing 1º-radical engaged in a 5-exo-trig
cyclization reaction and the 2º-radical so-formed then collapsed with ejection of a chlorine radical so
as to re-establish the carbon–carbon double bond with complete positional fidelity and thereby com-
pleting the synthesis of (+)-erythramine [(+)-11] (89 % from 15) [4].
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Scheme 2
Another alkaloid of interest to us is the lactol-containing compound tazettine (17) [5] which,
especially when considered in its ring-opened form 17b, quite clearly embodies a C3a-arylhexa -
hydroindole unit. Because this motif is encountered in numerous other Amaryllidaceae alkaloids, vari-
ous methods for its construction have been investigated [6].
The plan we adopted for preparing this unit is shown in Scheme 4 and involved engaging the
N-protected and propargylated 1-amino-2-aryl-2-cyclohexenes of the general form 18 in an intra -
molecular Alder-ene (IMAE) reaction thus producing a C3a-arylhexahydroindole 19 incorporating the
required Δ4-double bond as well as an exocyclic one at C3 [7]. Provided the latter alkene could be
oxidatively cleaved in a selective manner, this moiety should serve as a precursor to a carbonyl or
hydroxyl group often encountered at C3 in the above-mentioned natural products. Clearly, the utility of
such a process, if viable, would depend upon how readily or otherwise the substrates for the IMAE reac-
tion could be synthesized.
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Scheme 3
Our synthesis of the required N-protected and propargylated 1-amino-2-aryl-2-cyclohexenes is
shown in Scheme 5 and involves a silver cyanate-induced electrocyclic ring opening of the readily
available gem-dibromocyclopropane 6 (X = Br) and trapping of the intermediate π-allyl cation 20 with
cyanate ion [7]. The resulting allylic isocyanate 21 is itself trapped with added t-butanol, thus afford-
ing the isolable Boc-protected allylic amine 22 in 75 % yield. Since carbamate-protected amines are
likely to prevent the target substrates 18 from adopting the geometry required for the IMAE reaction,
the Boc-group within compound 22 was cleaved using TMSOTf in the presence of 2,6-lutidene or with
trifluoroacetic acid (TFA) alone and the resulting 1º-amine treated with o-nitrobenzenesulfonyl chlo-
ride (NsCl) and thereby affording nosylate 23 (73 % from 22). The sulfonamide-based protecting
group was chosen because of the likelihood of the associated nitrogen being able to assume a geo metry
that would allow for the desired cyclization reaction. The nosyl protecting group was also considered
a particularly attractive one because of the ease with which it can be removed using the phenylthiolate
anion. Suzuki–Miyaura cross-coupling of 3,4-methylenedioxyphenyl boronic acid (24) with cyclo-
hexenyl bromide 23 resulted in the formation of the 1-amino-2-aryl-2-cyclohexene 25 (69 %) which
was treated, successively, with sodium hydride then propargyl bromide to afford the first substrate, 26
(89 %), required to investigate the proposed IMAE reaction. In the event, subjecting this compound to
reaction with Pd(OAc)2 and the strong donor ligand bis(benzyl idene)ethylenediamine (BBEDA) in
refluxing benzene, conditions known to effect ene reactions in other systems, only resulted in the
dimerization of the substrate to give compound 27 as a ca. 1:1 mixture of diastereo isomers. In order
to prevent this unwanted process, the methyl-capped substrate 28 was prepared by straightforward
means and subjected to the same reaction conditions. Gratifyingly, the desired C3a-arylhexahydro -
indole 29 was now formed in 94 % yield and its structure confirmed by single-crystal X-ray analysis.
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Scheme 4
Substrate 30 (Scheme 6), incorporating a carbomethoxy group that could be used to establish the
lactol unit of tazettine, also participates in the desired IMAE reaction to give compound 31 in 55 %
yield. Efforts to exploit such reaction sequences in establishing an abbreviated and enantioselective syn-
thesis of natural product 17 are now underway.
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Scheme 5
NEW GOLD(I)-CATALYZED PROCESSES FOR NATURAL PRODUCTS SYNTHESIS
Gold-catalyzed processes are attracting increasing attention in natural products synthesis, not least
because of the novel and selective transformations such species can promote, and often under very mild
conditions [8]. Our interest in the area arose when we discovered that the highly versatile and now com-
mercially available Au(I) catalyst developed by Echavarren (vide infra) can effect the intramolecular
hydroarylation (IMHA) of a significant range of acetylenic ethers, esters, and amines, thus affording,
for example, coumarins, benzofurans, or dihydroquinolines [9]. As an extension of such work, we have
been investigating other reactions that this catalyst is capable of effecting and have now discovered that
it can promote intramolecular Michael additions of certain nucleophilic heterocycles to tethered ynones.
This process is best illustrated in connection with our very recent development of the first total synthe-
ses [10] of the furanosesquiterpenes crassifolone (32) and dihydrocrassifolone (33) [11].
The reaction sequence starts (Scheme 7) with the base-promoted coupling of the furan-substituted
iodopropane 34 with the terminal acetylene 35 and treatment of the ensuing product with tetra-n-butyl -
ammonium fluoride (TBAF) to give the alcohol 36 (76 % over two steps). Oxidation of the last com-
pound with pyridinium chlorochromate (PCC) then afforded the ynone 37 (90 %) that we anticipated
would engage in an acid-catalyzed intramolecular Michael addition reaction whereby the nucleophilic
C2 of the furan residue attacks at the proximate sp-hybridized carbon and so forming the six-membered
ring required in assembling the bicyclic framework of targets 32 and 33. In the event, all efforts to effect
this transformation of substrate 37 using any one of a range of protic or Lewis acids failed. In stark con-
trast, treatment of a dichloromethane solution of the same compound with 1 mol % of the Echavarren’s
catalyst at room temperature resulted in the quantitative formation, after just 15 minutes, of the desired
furannulated cyclohexane 38. We speculate that this remarkable transformation involves initial auration
at C2 of the substrate [12] and that this is followed by intramolecular Michael addition of this now
highly nucleophilic center to the sterically uncongested β-terminus of the tethered ynone. Protio-deau-
ration would then give compound 38, which is obtained as a single geometric isomer (and tentatively
assigned as possessing the illustrated E-configuration).
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Scheme 6
The elaboration of compound 38 to crassifolone and dihydro-analogue 33 involved its reaction
with methyl magnesium bromide in the presence of stoichiometric quantities of trimethylsilyl chloride
and catalytic quantities of the cuprous bromide/dimethyl sulfide complex. The ensuing silyl enol ether
39 (66 %) was treated with TBAF and dihydrocrassifolone (33) thereby obtained in 61 % yield.
Compound 33 could be converted into congener 32 (96 % at 50 % conversion) by successive treatment
with TMSOTf in the presence of triethylamine then IBX in the presence of MPO. The spectral data
obtained on each of the synthetically derived compounds 32 and 33 matched those reported [11] for the
corresponding natural product.
CHEMOENZYMATIC METHODS IN NATURAL PRODUCTS SYNTHESIS
The whole-cell biotransformation of arenes 40 using genetically engineered organisms such as P. putida
39-D or E. coli JM 109 (pDTG601) that over-express the enzyme toluene dioxygenase (TDO) or related
species allows, in optimal circumstances, for the formation of the corresponding cis-1,2-dihydro -
catechol 41 in high chemical yield and >99.8 % enantiomeric excess (Scheme 8) [13]. Given this and
the capacity to selectively manipulate the strongly differentiated functionality within compound 41,
such species can be considered as useful new chemical feedstocks for the synthesis of a wide range of
target compounds. Like others, we have become interested in using these metabolites as starting mate-
rials for the synthesis of various natural products and other biologically active compounds [14].
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Scheme 7
Some indication of the diversity of structures that can be obtained through chemical manipulation
of the cis-1,2-dihydrocatechols is highlighted in Fig. 1 which shows a range of target compounds our
group has prepared from these starting materials in recent years [15].
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Fig. 1
Of course, one of the challenges associated with using the above-mentioned cis-1,2-dihydro -
catechols in synthesis arises when there is a mismatch between the chirality of the starting material and
the target compound. While the enantiomeric enzyme, i.e., ent-TDO, is unlikely to be accessible there
are chemical means for obtaining the opposite enantiomeric form of certain of the cis-1,2-dihydro -
catechols. Thus, for example, Boyd and his colleagues have demonstrated [16] that when TDO acts on
the p-iodinated equivalent, 42, of arene 40, then (Scheme 9) a ca. 1:9 mixture of the enantiomeric diols
43 and 44 is obtained. Reductive deiodination of these metabolites, which can be achieved electro-
chemically or by Pd-catalyzed hydrogenolysis, affords the corresponding mixture of compounds 41 and
ent-41. Treatment of this mixture with certain organisms that express dehydrogenase enzymes results
in the selective aromatization of compound 45 to give catechol 46, which can be separated chromato-
graphically from the unaffected metabolite ent-41 that is thus obtained in essentially enantiomerically
pure form.
In a related vein, we have uncovered enantiomeric switching regimes that allow, in certain cir-
cumstances, for the conversion of cis-1,2-dihydrocatechol 41 into either enantiomeric form of various
derivatives. A useful example of such a regime arose during the course of our recently reported [15e]
synthesis of the tricyclic core of the novel antibacterial agent platencin (46), a natural product isolated
by Singh and co-workers from Streptomyces platensis MA7327 [17]. 
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Scheme 9
Our approach to this significant compound is shown in Scheme 10 and starts with the conversion
of the iodobenzene-derived cis-1,2-dihydrocatechol 41 (X = I) into the corresponding acetonide 47
(91 %) under standard conditions. The latter compound was then subjected to a Negishi cross-coupling
with the organozinc species 48. The triene 49 (62 %) thus obtained was heated in refluxing toluene (in
the presence of the free-radical inhibitor BHT) and thereby effecting a highly selective intramolecular
Diels–Alder (IMDA) reaction leading to adduct 50 (89 %) embodying the tricyclic framework of
 platencin. A further seven and relatively conventional steps were then used to convert the latter com-
pound into enone 51, the key intermediate associated with the Nicolaou and Rawal total syntheses of
platencin [18].
It also seems possible to obtain the enantiomer of enone 51 (i.e., ent-51) from the same cis-1,2-
dihydrocatechol, namely, compound 41 (X = I). Thus, the triene 52 (Scheme 11), which was readily
generated employing chemistry similar to that used to obtain the acetonide-protected variant 49,
engages in an IMDA reaction upon heating in refluxing xylene, but now this process involves addition
of the dienophile to the same face of the diene as occupied by the hydroxyl groups and thereby affords
adduct 53 (55 %). The precise origins of the facial selectivity associated with this cycloaddition process
remain unclear but they are presumably related to a stabilizing interaction between the dienophilic dou-
ble bond and the hydroxyl groups. The pseudo-enantiomeric relationship between compound 53 and
adduct 50 is emphasized by the expectation that chemistry analogous to that used in the conversion
50 → 51 would lead to compound ent-51, the core of ent-platencin (ent-48).
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Scheme 11
Related enantiomeric switching regimes involving IMDA processes wherein the dienophile is
attached, though ester linkages, to one or other of the hydroxyl groups of the cis-1,2-dihydrocatechols
have also been developed by us [19]. As such, and given the wide range of structurally diverse natural
products that can be prepared from the cis-1,2-dihydrocatechols (see Fig. 1) we anticipate that these
compounds will continue to play an important role in chemical synthesis for some time to come.
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